BISPHOSPHONATES FOR INCREASING THE TYPE 2 CHARACTER OF A MODIC CHANGE

• 收藏
• 分享

专利权人:

发明人:

Herriot Tabuteau,Jaro Karppinen

申请号：

US15977413

公开号：

US20180256611A1

申请日:

2018.05.11

申请国别(地区):

US

年份:

2018

代理人:

摘要：

Oral dosage forms of bisphosphonates, such as zoledronic acid, in an acid form or a salt form can be used to treat or alleviate pain or related conditions. Zoledronic acid also tends to speed up the conversion of M1-dominant to M2-dominant Modic changes and decrease the volume of M1-dominant Modic changes, which correlate with improvement in symptoms.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/